The Publications Office of the EU is in the process of updating some of the content on this website in the light of the withdrawal of the United Kingdom from the European Union. If the site contains content that does not yet reflect the withdrawal of the United Kingdom, it is unintentional and will be addressed.

Services - 174262-2019

Display compact view

15/04/2019    S74    Agencies - Services - Call for expressions of interest - Not specified 

Portugal-Lisbon: Call for expressions of interest in membership of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction

2019/S 074-174262

Call for expressions of interest


Section I: Contracting authority

I.1)Name, addresses and contact point(s)

Official name: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, PORTUGAL

National ID: PT
Postal address: Praça Europa 1, Cais do Sodré
Town: Lisbon
Postal code: 1249-289
Country: Portugal (PT)
Contact point(s)
For the attention of: Vivianne Rodriguez, Procurement Officer
Telephone: +351 211210298
Fax: +351 210193502

E-mail: info.procurement@emcdda.europa.eu

Internet address(es)

General address of the contracting authority (URL): http://www.emcdda.europa.eu

Electronic access to information (URL): http://www.emcdda.europa.eu/about/sc/call-scientific-committee-2019

Electronic submission of applications (URL): SciCom19@emcdda.europa.eu

Further information can be obtained from:
The above mentioned contact point(s)
Specifications and additional documents can be obtained from:
The above mentioned contact point(s)
Applications must be sent to:
The above mentioned contact point(s)
I.2)Type of the contracting authority
European institution/agency or international organisation
I.3)Main activity
Other: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
I.4)Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: no


Section II: Object of the call for expressions of interest

II.1)Title attributed to the call for expressions of interest
Call for expressions of interest in membership of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction
II.2)Type of contract and location of works, place of delivery or of performance
Services
Service category No: 27 Other services
Main site or location of works, place of delivery or of performance: EMCDDA in Lisbon, Portugal
NUTS code: PT17
II.3)Description of the field or fields covered by the call for expressions of interest:
This call is addressed to scientists who wish to be considered for membership of the EMCDDA Scientific Committee.

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), based in Lisbon, PORTUGAL, was established to provide the European Union and its Member States with 'factual, objective, reliable and comparable information at European level concerning drugs and drug addiction and their consequences' (1). For additional information on the EMCDDA, please see http://www.emcdda.europa.eu.

EMCDDA Scientific Committee
The EMCDDA Scientific Committee is set up by Article 13 of the Regulation (EC) No 1920/2006 of the European Parliament and of the Council on the European Monitoring Centre for Drugs and Drug Addiction (recast) (1).
The task of the Scientific Committee is to assist the Management Board and the Director of the EMCDDA by delivering an opinion on any scientific matter concerning the Centre's activity which the Management Board or the Director may submit to it.
In addition, the risk assessment of new psychoactive substances is carried out by the Scientific Committee, in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) (2). In carrying out the risk assessment of new psychoactive substances, the Scientific Committee (extended, as required) needs to be able to assess public health and social risks posed by new psychoactive substances.
The Scientific Committee consists of, at most, 15 well-known scientists appointed by the Management Board in view of their scientific excellence and their independence. The members of the Scientific Committee shall be appointed for a three-year period, which shall be renewable, in a personal capacity and shall give their opinions completely independently of the Member States and the European Union Institutions (3). They shall possess proven scientific excellence, both in terms of experience and expertise, in relation to the fields of the mandate of the EMCDDA, namely:
(a) basic biological, neurobiological and behavioural research (including aetiological and addictive behaviour research, pharmacology and toxicology);
(b) population-based research and epidemiology (including surveys and ethnographic studies);
(c) demand reduction (including prevention, treatment, harm reduction and reintegration);
(d) supply, supply reduction and crime;
(e) drug policy (including laws, economic issues and strategies).
Upon appointment, each member of the EMCDDA Scientific Committee shall sign a declaration of independence in relation to the performance of his/her duties in and for this body and shall fill in and sign a written declaration of interest covering current and past interests up to five years before the date of the declaration. These declarations will be made available for public scrutiny on the EMCDDA website, with due respect to EU rules on protection of personal data.
Meetings of the Scientific Committee are generally held twice a year at the EMCDDA premises in Lisbon. The vehicular working language of the Scientific Committee is English. Members are expected to attend these meetings, as well as risk assessment meetings in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). If a member does not attend two consecutive regular Scientific Committee meetings, the membership may be withdrawn.
Members of the Scientific Committee will be entitled to an indemnity for each meeting day. Members will also receive travel and subsistence allowance in accordance with the EMCDDA’s policy for the reimbursement of travel and accommodation expenses.
The rules applicable to the EMCDDA Scientific Committee require that its members are nationals of a Member State of the European Union (EU) or of a Country which has concluded an agreement with the latter for the purpose of the participation in the work of the EMCDDA. This requirement is a condition of eligibility for the selection and the appointment of the members of the EMCDDA Scientific Committee. If this condition is not met, this will determine the exclusion of the concerned person from the selection process and/or the termination of his/her appointment as member of the EMCDDA Scientific Committee, from the moment when the above referred condition is not met.
With regard to the above, and by taking into account the on-going process concerning the withdrawal of the United Kingdom (UK) from the EU (Brexit), United Kingdom’s nationals will no longer satisfy this condition as of the date of this withdrawal, to be determined in accordance with Article 50 of the Treaty of the European Union (TFEU). However, if at this date the Agreement to be concluded between the EU and the UK on this withdrawal (Withdrawal Agreement, as endorsed by the European Council on 25.11.2018) enters into force, United Kingdom’s nationals will be considered to meet the aforementioned condition of nationality during the transition period established by this Agreement.

Further information on this call, including procedures, arrangements and the requirements for eligibility and selection, are available from the EMCDDA website http://www.emcdda.europa.eu/about/sc/call-scientificcommittee-2019

Applications shall be sent to SciCom19@emcdda.europa.eu.

Closing date:
The closing date for submission of applications is 17.5.2019 at 23:59, Lisbon time (date and hour of e-mail). The EMCDDA reserves the right to disregard any expressions of interest sent after that date.

(1) OJ L 376, 27.12.2006, p. 1. See: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=OJ:L:2006:376:TOC

(2) OJ L 305, 21.11.2017, p. 1–7. See: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2017.305.01.0001.01.ENG

(3) Information on the current composition of the EMCDDA Scientific Committee, agendas and minutes of meetings, adopted formal opinions and rules of procedure are available on http://www.emcdda.europa.eu/about/sc

II.4)Information about lots (for information about lots, use Annex B as many times as there are lots)
This call for expressions of interest is divided into lots: no
Applications may be submitted for: one lot only
II.5)Information about subcontracting
The subcontracting is accepted: no


Section IV: Procedure

IV.1)Type of procedure
Restricted
IV.2)Grounds for exclusion
Applicants shall be excluded from participating in a contract if:
(a) they are bankrupt, being wound up or have suspended business activities, their affairs are being administered by the court, they have entered into an arrangement with creditors or similar measures or are the subject of any proceedings of that nature, or are in any analogous situation arising from a similar procedure provided for in national legislation or regulations;
(b) they have been convicted of an offence concerning their professional conduct by a judgment which is not open to appeal;
(c) they have been guilty of grave professional misconduct;
(d) they have not fulfilled obligations relating to the payment of social security contributions or taxes;
(e) they are guilty of serious misrepresentation in supplying the information required by the authorizing department;
(f) other: n/a.
IV.3)Selection criteria:

Procedures and arrangements for the selection and appointment of the members of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) are available at: http://www.emcdda.europa.eu/about/sc/call-scientific-committee-2019

IV.4)Administrative information
IV.4.1) File reference number:
SciCom19
IV.4.2) Period of validity of the list resulting from this call for expressions of interests:
Expiry date of the list resulting from the call for expressions of interest:
Date: 31.12.2022
IV.4.3) Time-limit for the submission of applications:
Date: 17.05.2019
IV.4.4) Language(s) in which applications may be submitted:
Official EU language(s): English


Section VI: Complementary information

VI.3)Date of dispatch of this notice:
3.4.2019